Rhabdomyosarcoma

Current Problems in Cancer

Volumn 32, Issue 1, 2008, Pages 7-34

  Paulino, Arnold C ^a   Okcu, Mehmet Fatih ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; VINCRISTINE;

ARTICLE; AUTOPSY; BILE DUCT CANCER; BLADDER CANCER; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL MALFORMATION; EMBRYONAL RHABDOMYOSARCOMA; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; INCIDENCE; LIMB; ORBIT CANCER; OVERALL SURVIVAL; PARAMENINGEAL DISORDER; PEDIATRICS; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; RETROPERITONEAL CANCER; RHABDOMYOSARCOMA; TESTIS CANCER; TRUNK; UNITED STATES; UTERINE CERVIX CANCER; UTERUS CANCER; VULVA CANCER;

CHILD; DISEASE-FREE SURVIVAL; GUIDELINES AS TOPIC; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM STAGING; PROGNOSIS; RECURRENCE; RHABDOMYOSARCOMA; UROGENITAL NEOPLASMS;

EID: 38349026249     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2007.11.001     Document Type: Article

References (97)

1. Ries LAG, Smith MA, Burney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program. National Cancer Institute, SEER Program, NIH, 1999; Pub No. 99-4649.
2. Stiller C.A., and Parkin D.M. International variations in the incidence of childhood soft-tissue sarcomas. Paediatr Perinat Epidemiol 8 (1994) 107-119
3. Ruymann F.B., Maddux H.R., Ragab A., et al. Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children's Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children's Cancer Study Group and the Pediatric Intergroup Statistical Center). Med Pediatr Oncol 16 (1988) 33-39
4. Hennekam R.C. Costello syndrome: an overview. Am J Med Genet 117C (2003) 42-48
5. Miller R.W., and Rubinstein J.H. Tumors in Rubinstein-Taybi syndrome. Am J Med Genet 56 (1995) 112-115
6. Sung L., Anderson J.R., Arndt C., et al. Neurofibromatosis in children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study IV. J Pediatr 144 (2004) 666-668
7. Diller L., Sexsmith E., Gottlieb A., et al. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 95 (1995) 1606-1611
8. Grufferman S., Schwartz A.G., Ruymann F.B., et al. Parents' use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control 4 (1993) 217-224
9. Hicks N., Zack M., Caldwell G.G., et al. Childhood cancer and occupational radiation exposure in parents. Cancer 53 (1984) 1637-1643
10. Parham D.M., Webber B., Holt H., et al. Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Cancer 67 (1991) 3072-3080
11. Dias P., Parham D.M., Shapiro D.N., et al. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol 137 (1990) 1283-1291
12. Crist W.M., Anderson J.R., Meza J.L., et al. Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19 (2001) 3091-3102
13. Scrable H.J., Witte D.P., Lampkin B.C., et al. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 329 (1987) 645-647
14. Fredericks W.J., Galili N., Mukhopadhyay S., et al. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcoma is a more potent transcriptional activator than PAX3. Mol Cell Biol 15 (1995) 1522-1535
15. Sorensen P.H.B., Lynch J.C., Qualman S.J., et al. PAX3-FKHR and PAX7-FKHR gene fusios are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 20 (2002) 2672-2679
16. Newton Jr. W.A., Soule E.H., Hamoudi A.B., et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol 6 (1988) 67-75
17. Oberlin O., Rey A., Anderson J., et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment: results of an international workshop. J Clin Oncol 19 (2001) 197-204
18. Orbach D., Brisse H., Helfre S., et al. Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary. Expert Opin Pharmacother 4 (2003) 2165-2174
19. Benk V., Rodary C., Donaldson S.S., et al. Parameningeal rhabdomyosarcoma: results of an international workshop. Int J Radiat Oncol Biol Phys 36 (1996) 533-540
20. Paulino A.C. Role of radiation therapy in parameningeal rhabdomyosarcoma. Cancer Invest 17 (1999) 223-230
21. Wharam M., Beltangady M.S., Heyn R.M., et al. Pediatric orofacial and laryngopharyngeal rhabdomyosarcoma: an Intergroup Rhabdomyosarcoma Study report. Arch Otolaryngol Head Neck Surg 113 (1987) 1225-1227
22. Walterhouse D.O., Pappo A.S., Baker K.S., et al. Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence: a report from the Intergroup Rhabdomyosarcoma Study Group. Cancer 92 (2001) 3135-3146
23. Lawrence Jr. W., Hays D., Heyn R., et al. Lymphatic metastases with childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study. Cancer 60 (1987) 910-915
24. Hays D.M., Raney Jr. R.B., Lawrence Jr. W., et al. Bladder and prostatic tumors in the Intergroup Rhabdomyosarcoma Study (IRS-I). Cancer 50 (1982) 1472-1482
25. Maurer H., Gehan E., Beltangady M., et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 71 (1993) 1904-1923
26. Breneman J.C., and Wiener E.S. Issues in the local control of rhabdomyosarcoma. Med Pediatr Oncol 35 (2000) 104-109
27. Leuschner I., Newton Jr. W.A., Schmidt D., et al. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region. A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 17 (1993) 221-230
28. Martelli H., Oberlin O., Rey A., et al. Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: a report from the study committee of the International Society of Pediatric Oncology. J Clin Oncol 17 (1999) 2117-2122
29. Copeland L.J., Sneige N., Stringer A., et al. Alveolar rhabdomyosarcoma of the female genitalia. Cancer 56 (1985) 849-855
30. Heyn R., Beltangady M., Hays D., et al. Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study. J Clin Oncol 7 (1989) 200-207
31. Raney Jr. R.B., Ragab A.H., Ruymann F.B., et al. Soft-tissue sarcoma of the trunk in childhood. Results of the Intergroup Rhabdomyosarcoma Study. Cancer 49 (1982) 2612-2616
32. Hays D.M., Donaldson S.S., Shimada H., et al. Primary and metastatic rhabdomyosarcoma in the breast: neoplasms of adolescent females: a report from the Intergroup Rhabdomyosarcoma Study. Med Pediatr Oncol 29 (1997) 181-189
33. Ortega J.A., Wharam M., Gehan E.A., et al. Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma study. J Clin Oncol 9 (1991) 796-801
34. Beech T.R., Moss R.L., Anderson J.A., et al. What comprises appropriate therapy for children/adolescents with rhabdomyosarcoma arising in the abdominal wall?. A report from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Surg 34 (1999) 668-671
35. Raney R.B., Soner J.A., Walterhouse D.O., et al. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study-IV, 1991-1997. Pediatr Blood Cancer 42 (2004) 618-625
36. Ruymann F.B., Raney Jr. R.B., Crist W.M., et al. Rhabdomyosarcoma of the biliary tree in childhood. A Report from the Intergroup Rhabdomyosarcoma Study. Cancer 56 (1985) 575-581
37. Spunt S.L., Anderson J.R., Teot L.A., et al. Routine brain imaging is unwarranted in asymptomatic patients with rhabdomyosarcoma arising outside the head and neck region that is metastatic at diagnosis: a report from the Intergroup Rhabdomyosarcoma Study Group. Cancer 92 (2001) 121-125
38. Breneman J.C., Lyden E., Pappo A.S., et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21 (2003) 78-84
39. Paulino A.C., Nguyen T.X., and Barker Jr. J.L. Brain metastasis in children with sarcoma, neuroblastoma and Wilms' tumor. Int J Radiat Oncol Biol Phys 57 (2003) 177-183
40. Raney R.B., Maurer H.M., Anderson J.R., et al. The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons from the IRS-I through IRS-IV studies as a background for the current IRS-V treatment protocols. Sarcoma 5 (2001) 9-15
41. Ferrari A., Casanova M., Bisogno G., et al. Rhabdomyosarcoma in infants younger than one year old: a report from the Italian Cooperative Group. Cancer 97 (2003) 2597-2604
42. Simon J.H., Paulino A.C., Ritchie J.M., et al. Presentation, prognostic factors and patterns of failure in adult rhabdomyosarcoma. Sarcoma 7 (2003) 1-7
43. Esnaola N.F., Rubin B.P., Baldini E.H., et al. Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg 234 (2001) 215-223
44. Hawkins W.G., Hoos A., Antonescu C.R., et al. Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer 91 (2001) 794-803
45. Little D.J., Ballo M.T., Zagars G.K., et al. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer 95 (2002) 377-388
46. Ferrari A., Dileo P., Casanova M., et al. Rhabdomyosarcoma in adults: a retrospective analysis of 171 patients treated at a single institution. Cancer 98 (2003) 571-580
47. Schalow E.L., and Broecker B.H. Role of surgery in children with rhabdomyosarcoma. Med Pediatr Oncol 41 (2003) 1-6
48. Hugosson C.O., Nyman R.S., Cappelen-Smith J.M., et al. Ultrasound-guided biopsy of abdominal and pelvic lesions in children. A comparison between fine needle aspiration and 1.2 mm needle core biopsy. Pediatr Radiol 29 (1999) 31-36
49. Blakely M.L., Lobe T.E., Anderson J.R., et al. Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma?. J Pediatr Surg 34 (1999) 736-742
50. Neville H.L., Andrassy R.J., Lobe T.E., et al. Preoperative staging: prognostic factors and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg 35 (2000) 317-321
51. Hays D.M., Lawrence Jr. W., Crist W.M., et al. Partial cystectomy in the management of rhabdomyosarcoma pf the bladder: a report from the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg 25 (1990) 719-723
52. Blatt J., Snyderman C., Wollman M.R., et al. Delayed resection in the management of non-orbital rhabdomyosarcoma of the head and neck in childhood. Med Pediatr Oncol 29 (1997) 294-298
53. Hays D.M., Raney R.B., Crist W.M., et al. Secondary surgical procedures to evaluate primary tumor status in patients with chemotherapy responsive Stage III and IV sarcomas: a report from the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg 25 (1990) 1100
54. Stobbe G.C., and Dargeoaon H.W. Embryonal rhabdomyosarcoma of the head and neck in children and adolescents. Cancer 3 (1950) 826-836
55. Donaldson S.S., Meza J., Breneman J.C., et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma: a report from the IRSG. Int J Radiat Oncol Biol Phys 51 (2001) 718-728
56. Schuck A., Mattke A.C., Schmidt B., et al. Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?. J Clin Oncol 22 (2004) 143-149
57. Wolden S.L., Anderson J.R., Crist W.M., et al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 17 (1999) 3468-3475
58. Paulino A.C., Simon J.H., Zhen W., et al. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 48 (2000) 1489-1495
59. Fiorollo A., Migliorati R., Vassallo P., et al. Radiation late effects in children treated for orbital rhabdomyosarcoma. Radiother Oncol 53 (1999) 143-148
60. Raney Jr. B., Heyn R., Hays D.M., et al. Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder or prostate: a report from the Intergroup Rhabdomyosarcoma Study Committee. Cancer 71 (1993) 2387-2394
61. Paulino A.C. Late effects of radiothery for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys 60 (2004) 265-274
62. Heyn R., Haeberlen V., Newton W.A., et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol 11 (1993) 262-270
63. Michalski J.M., Sur R.K., Harms W.B., et al. Three-dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys 33 (1995) 985-991
64. Wolden S.L., La T.H., LaQuaglia M.P., et al. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma. Cancer 97 (2003) 179-185
65. Paulino A.C., and Skwarchuk M. Intensity modulated radiation therapy in the treatment of children. Med Dosim 27 (2002) 115-120
66. Hug E.B., Adams J., Fitzek M., et al. Fractionated, three-dimensional planning assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys 47 (2000) 979-984
67. Merchant T.E., Parsh N., del Valle P.L., et al. Brachytherapy for pediatric soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 46 (2000) 427-432
68. Nag S., Tippin D., and Ruymann F. Long-term morbidity in children treated with fractionated high-dose-rate brachytherapy for soft tissue sarcomas. J Pediatr Hematol Oncol 25 (2003) 448-452
69. Crist W., Gehan E.A., Ragab A.H., et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13 (1995) 610-630
70. Maurer H.M., Beltangady, Gehan E.A., et al. The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer 61 (1988) 209-220
71. Dagher R., and Helman L. Rhabdomyosarcoma: an overview. Oncologist 4 (1999) 34-44
72. Wilbur J.R. Combination chemotherapy for embryonal rhabdomyosarcoma. Cancer Chemother Rep 58 (1974) 281
73. Baker K.S., Anderson J.R., Link M.P., et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 18 (2000) 2427-2434
74. Furman W.L., Stewart C.F., Poquette C.A., et al. Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children. J Clin Oncol 17 (1999) 1815-1824
75. Blaney S.M., Needle M.N., Gillespie A., et al. Phase II trial of topotecan administered as a 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute and Children's Cancer Group study. Clin Cancer Res 4 (1998) 357-360
76. Pappo A.S., Lyden E., Breneman J., et al. Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an Intergroup Rhabdomyosarcoma Study. J Clin Oncol 19 (2001) 213-219
77. Knowles D.M., Jakobiec F.A., Potter G.D., et al. Ophthalmic striated muscle neoplasms. Surv Ophthalmol 21 (1976) 219-261
78. Kodet R., Newton Jr. W.A., Hamoudi A.B., et al. Orbital rhabdomyosarcoma and related tumors in childhood: relationship of morphology to prognosis: an Intergroup Rhabdomyosarcoma Study. Med Pediatr Oncol 29 (1997) 51-60
79. Wharam M., Beltangady M., Hays D., et al. Localized orbital rhabdomyosarcoma: an interim report of the Intergroup Rhabdomyosarcoma Study Committee. Ophthalmology 94 (1987) 251-254
80. Carrie C., and Freeman C. Are all consents really informed?. Int J Radiat Oncol Biol Phys 51 (2001) 287
81. Tefft M., Fernandez C., Donaldson M., et al. Incidence of meningeal involvement by rhabdomyosarcoma of the head and neck in children: a report from the Intergroup Rhabdomyosarcoma Study (IRS). Cancer 42 (1978) 253-258
82. Gasparini M., Lombardi F., Gianni M.C., et al. Questionable role of CNS radioprophylaxis in the therapeutic management of childhood rhabdomyosarcoma. J Clin Oncol 8 (1990) 1854-1857
83. Michalski J.M., Meza J., Breneman J.C., et al. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Int J Radiat Oncol Biol Phys 59 (2004) 1027-1038
84. Paulino A.C., Bauman N., Simon J.H., et al. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation. Med Pediatr Oncol 41 (2003) 118-122
85. Baker K.S., Anderson J.R., Link M.P., et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 18 (2000) 2427-2434
86. Hays D. The management of rhabdomyosarcoma in children and young adults. World J Surg 4 (1980) 15-28
87. Hays D. Bladder/prostate rhabdomyosarcoma: results of the multi-institutional trials of the Intergroup Rhabdomyosarcoma Study. Semin Surg Oncol 9 (1993) 520-523
88. Arndt C., Rodeberg D., Breitfeld P.P., et al. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma?. Results from Intergroup Rhabdomyosarcoma Study IV. J Urol 171 (2004) 2396-2403
89. Yeung C.K., Ward H.C., Ransley P.G., et al. Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood. Br J Cancer 70 (1994) 1000-1003
90. Arndt C.A.S., Donaldson S.S., Anderson J.R., et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?. Cancer 91 (2001) 2454-2468
91. Andrassy R.J., Corpron C.A., Hays D., et al. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III. J Pediatr Surg 31 (1996) 191-196
92. Neville H.L., Andrassy R.J., Lobe T.E., et al. Preoperative staging, prognostic factors and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg 35 (2000) 317-321
93. McMulkin H.M., Yanchar N.L., Fernandez C.V., et al. Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma. Pediatr Surg Int 19 (2003) 453-456
94. Spunt S.L., Lobe T.E., Pappo A.S., et al. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg 35 (2000) 309-316
95. Raney R.B., Crist W.M., Maurer H.M., et al. Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response: a report from the Intergroup Rhabdomyosarcoma Study I. Cancer 52 (1983) 44-50
96. Klingebiel T., Pertl U., Hess C., et al. Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial. Med Pediatr Oncol 30 (1998) 269-275
97. Pappo A.S., Anderson J.R., Crist W.M., et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 17 (1999) 3487-3493